ZA946321B - Antipsychotic method - Google Patents
Antipsychotic methodInfo
- Publication number
- ZA946321B ZA946321B ZA946321A ZA946321A ZA946321B ZA 946321 B ZA946321 B ZA 946321B ZA 946321 A ZA946321 A ZA 946321A ZA 946321 A ZA946321 A ZA 946321A ZA 946321 B ZA946321 B ZA 946321B
- Authority
- ZA
- South Africa
- Prior art keywords
- antipsychotic method
- antipsychotic
- schizophrenia
- susceptible
- treating
- Prior art date
Links
- 230000000561 anti-psychotic effect Effects 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000020186 Schizophreniform disease Diseases 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Epoxy Resins (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10928593A | 1993-08-19 | 1993-08-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA946321B true ZA946321B (en) | 1996-02-19 |
Family
ID=22326851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA946321A ZA946321B (en) | 1993-08-19 | 1994-08-19 | Antipsychotic method |
Country Status (23)
Country | Link |
---|---|
US (3) | US5677313A (xx) |
EP (1) | EP0714394B1 (xx) |
JP (1) | JP3474575B2 (xx) |
KR (1) | KR960703908A (xx) |
CN (1) | CN1040979C (xx) |
AT (1) | ATE202353T1 (xx) |
CA (1) | CA2169838C (xx) |
CZ (1) | CZ42796A3 (xx) |
DE (1) | DE69427537T2 (xx) |
DK (1) | DK0714394T3 (xx) |
ES (1) | ES2160127T3 (xx) |
FI (1) | FI960748A (xx) |
GR (1) | GR3036587T3 (xx) |
HU (1) | HU222116B1 (xx) |
IL (1) | IL110727A (xx) |
NO (1) | NO310597B1 (xx) |
NZ (2) | NZ336596A (xx) |
PT (1) | PT714394E (xx) |
SG (1) | SG55072A1 (xx) |
TW (1) | TW442285B (xx) |
UA (1) | UA43347C2 (xx) |
WO (1) | WO1995005379A1 (xx) |
ZA (1) | ZA946321B (xx) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0714394T3 (da) * | 1993-08-19 | 2001-10-01 | Novo Nordisk As | Antipsykotisk fremgangsmåde |
US5998404A (en) | 1994-10-24 | 1999-12-07 | Eli Lilly And Company | Heterocyclic compounds and their use |
US5605908A (en) * | 1994-10-24 | 1997-02-25 | Eli Lilly And Company | Heterocyclic compounds and their use |
US5821370A (en) * | 1994-10-24 | 1998-10-13 | Eli Lilly And Company | Heterocyclic compounds and their preparation and use |
US5726193A (en) * | 1994-10-31 | 1998-03-10 | Eli Lilly And Company | Method for treating anxiety |
US5488056A (en) * | 1994-10-31 | 1996-01-30 | Eli Lilly And Company | Method for treating anxiety |
US5574028A (en) * | 1994-10-31 | 1996-11-12 | Eli Lilly And Company | Method for treating anxiety |
PE17897A1 (es) * | 1995-02-17 | 1997-06-12 | Lilly Co Eli | Formulacion transdermica en parche del 3-(4-butiltio)-1,2,5-tiadiazol-3-il)-1-azabiciclo (2,2,2) octano |
US5852037A (en) * | 1995-11-13 | 1998-12-22 | Eli Lilly And Company | Method for treating anxiety |
US5763457A (en) * | 1995-11-13 | 1998-06-09 | Eli Lilly And Company | Method for treating anxiety |
EP0874828A4 (en) * | 1995-12-06 | 1999-09-01 | Lilly Co Eli | PAIN TREATMENT COMPOSITIONS |
US20020022056A1 (en) | 1997-02-14 | 2002-02-21 | Burkhard Schlutermann | Oxacarbazepine film-coated tablets |
WO1998046227A1 (en) * | 1997-04-11 | 1998-10-22 | Eli Lilly And Company | Composition for treating pain |
EP1009403A4 (en) * | 1997-04-11 | 2002-08-28 | Lilly Co Eli | METHOD FOR TREATING SCHIZOPHRENIA |
US20040023951A1 (en) * | 2001-06-18 | 2004-02-05 | Bymaster Franklin Porter | Combination therapy for treatment of psychoses |
JP5693229B2 (ja) * | 2007-11-21 | 2015-04-01 | アッヴィ・バハマズ・リミテッド | ニコチンアセチルコリン受容体活性モジュレータとしてのビアリール置換アザ二環式アルカン誘導体 |
EP2296471A4 (en) | 2008-05-15 | 2012-03-14 | Univ Toledo | MUSCARIC ACID AGONISTS AS COGNITIVE ENHANCERS |
WO2012149524A1 (en) | 2011-04-29 | 2012-11-01 | The University Of Toledo | Muscarinic agonists as enhancers of working memory and cognitive flexibility |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2061502T3 (es) * | 1986-06-27 | 1994-12-16 | Beecham Group Plc | Nuevos n-heterociclos biciclicos puenteados. |
US4977176A (en) * | 1987-01-31 | 1990-12-11 | Sandoz Ltd. | Pilocarpine compounds which are used as pharmaceutical agents |
NZ227841A (en) * | 1988-02-12 | 1991-08-27 | Merck Sharp & Dohme | Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions |
DK198590D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
US5418240A (en) * | 1990-08-21 | 1995-05-23 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
DK0714394T3 (da) * | 1993-08-19 | 2001-10-01 | Novo Nordisk As | Antipsykotisk fremgangsmåde |
-
1994
- 1994-08-18 DK DK94924710T patent/DK0714394T3/da active
- 1994-08-18 EP EP94924710A patent/EP0714394B1/en not_active Expired - Lifetime
- 1994-08-18 ES ES94924710T patent/ES2160127T3/es not_active Expired - Lifetime
- 1994-08-18 KR KR1019960700807A patent/KR960703908A/ko active IP Right Grant
- 1994-08-18 SG SG1996004798A patent/SG55072A1/en unknown
- 1994-08-18 PT PT94924710T patent/PT714394E/pt unknown
- 1994-08-18 CN CN94193738A patent/CN1040979C/zh not_active Expired - Fee Related
- 1994-08-18 UA UA96020583A patent/UA43347C2/uk unknown
- 1994-08-18 CZ CZ96427A patent/CZ42796A3/cs unknown
- 1994-08-18 DE DE69427537T patent/DE69427537T2/de not_active Expired - Fee Related
- 1994-08-18 AT AT94924710T patent/ATE202353T1/de not_active IP Right Cessation
- 1994-08-18 JP JP50669595A patent/JP3474575B2/ja not_active Expired - Fee Related
- 1994-08-18 CA CA002169838A patent/CA2169838C/en not_active Expired - Fee Related
- 1994-08-18 WO PCT/DK1994/000309 patent/WO1995005379A1/en not_active Application Discontinuation
- 1994-08-18 NZ NZ336596A patent/NZ336596A/en unknown
- 1994-08-18 HU HU9600363A patent/HU222116B1/hu not_active IP Right Cessation
- 1994-08-18 NZ NZ271313A patent/NZ271313A/en unknown
- 1994-08-19 ZA ZA946321A patent/ZA946321B/xx unknown
- 1994-08-19 IL IL11072794A patent/IL110727A/en not_active IP Right Cessation
-
1995
- 1995-02-15 TW TW084101438A patent/TW442285B/zh not_active IP Right Cessation
- 1995-06-05 US US08/462,931 patent/US5677313A/en not_active Expired - Fee Related
- 1995-06-05 US US08/465,215 patent/US5679686A/en not_active Expired - Lifetime
- 1995-06-05 US US08/463,615 patent/US5968926A/en not_active Expired - Fee Related
-
1996
- 1996-02-16 NO NO19960620A patent/NO310597B1/no not_active IP Right Cessation
- 1996-02-19 FI FI960748A patent/FI960748A/fi unknown
-
2001
- 2001-09-11 GR GR20010401444T patent/GR3036587T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG55072A1 (en) | Antipsychotic method | |
GB2275264B (en) | Waste treatment process employing oxidation | |
EP0814814A4 (en) | METHODS OF TREATING THROMBOSIS | |
SG55071A1 (en) | Antipsychotic method | |
AU1623295A (en) | Ga- and/or In-containing AsGe sulfide glasses | |
HUT70218A (en) | Process for the manufacture of (s)-3-amino-1-substituted-pyrrolidines | |
AU1792288A (en) | Method for treating schizophrenia | |
HUT73647A (en) | Process for refining cycclodextrin | |
IL128028A0 (en) | Treatment of psychotic disorders | |
DE69419598D1 (de) | Abstichverfahren für hochofen | |
SG44613A1 (en) | Process for the hydroxycarbonylation of butadiene | |
AU7018794A (en) | Methods for treating pathologies | |
GB9501401D0 (en) | Method for treating industrial effluent | |
HU9402423D0 (en) | Process for the manufacture of phenoxyphenoxyalkyl derivatives | |
GB2279070B (en) | Process for the treatment of sewage | |
GB2279887B (en) | Sewage treatment process | |
HK1000840A1 (en) | Process for the production of polyurethane lens | |
JO1770B1 (en) | New formulations mainly composed of derivatives of sleepjestrol and the methods necessary to produce them | |
EP0678495A3 (de) | Verfahren zur Reinigung von Perfluoralkylbromiden oder Perfluoralkylendibromiden. | |
GB9321253D0 (en) | Process for the production of s.s.e.d.d.s | |
GB9321433D0 (en) | Treatment of inflammatory dermatoses | |
HU9200787D0 (en) | Process for the production of fish-foods from protein waste |